Can Circulating Cell-Free DNA or Circulating Tumor DNA Be a Promising Marker in Ovarian Cancer?

Figure 1

The development history of cfDNA/ctDNA is detected in many diseases and cancers. The detection can involve the concentration and integrity, mutation, methylation of cfDNA/ctDNA, and so on. Analyses of cfDNA/ctDNA can be used to early detection and diagnosis, therapy responses monitoring, recurrence prediction, drug resistance assessment, and prognosis judgment.